Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.

TSX:SVA - Post by User

Sernova Corp > Novo Nordisk makes a move

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon Jan 09, 2023 10:29am

197 Views

Post# 35210984

RE:Novo Nordisk makes a move

I guess their own cells they were working on are a bust? I wonder if they are still working with these guys for the delivery device:

https://procyon-technologies.com/stem-cell-based-therapy-for-type-1-diabetes/

<< Previous

Bullboard Posts

Next >>

PharmAla Biotech launches educational portal for MDMA